We are live on
!
Find out more
AAP
Ardsley Advisory Partners Portfolio holdings
AUM
$960M
1-Year Est. Return
207.76%
This Fund
S&P 500
This Quarter
Est. Return
+14.96%
1 Year Est. Return
+207.76%
3 Year Est. Return
+554.53%
5 Year Est. Return
+728.66%
10 Year Est. Return
+4,084.52%
AUM
$627M
AUM Growth
+$181M
(+41%)
Cap. Flow
+$130M
Cap. Flow
% of AUM
20.82%
Top 10 Holdings %
Top 10 Hldgs %
46.99%
Holding
210
New
76
Increased
33
Reduced
30
Closed
60
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Guardant Health
GH
|
+$17.7M |
| 2 |
State Street SPDR S&P Biotech ETF
XBI
|
+$9.51M |
| 3 |
Twilio
TWLO
|
+$7.81M |
| 4 |
STKL
SunOpta
STKL
|
+$7.64M |
| 5 |
LHCG
LHC Group LLC
LHCG
|
+$7.47M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walt Disney
DIS
|
+$10.6M |
| 2 |
Medifast
MED
|
+$9.84M |
| 3 |
AY
Atlantica Sustainable Infrastructure plc Ordinary Shares
AY
|
+$9M |
| 4 |
First Solar
FSLR
|
+$8.39M |
| 5 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
+$7.43M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.98% |
| 2 | Healthcare | 15.11% |
| 3 | Industrials | 12.05% |
| 4 | Consumer Discretionary | 6.3% |
| 5 | Consumer Staples | 5.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ATVI
101
CALL
DELISTED
Activision Blizzard
ATVI
| $475K | 0.08% |
+8,000
| New | +$443K |
|
|
SAIL
102
DELISTED
SailPoint Technologies Holdings, Inc. Common Stock
SAIL
| $472K | 0.08% |
+20,000
| New | +$437K |
|
103
Clean Energy Fuels
CLNE
$425M
| $468K | 0.07% |
200,000
+25,000
| +14% | +$53K |
|
104
Plug Power
PLUG
$2.92B
| $468K | 0.07% |
+150,000
| New | +$456K |
|
105
Biogen
BIIB
$30.7B
| $445K | 0.07% |
+1,500
| New | +$416K |
|
106
Stryker
SYK
$133B
| $420K | 0.07% |
+2,000
| New | +$415K |
|
107
Analog Devices
ADI
$179B
| $416K | 0.07% |
+3,500
| New | +$394K |
|
|
PFPT
108
DELISTED
Proofpoint, Inc.
PFPT
| $402K | 0.06% |
3,500
-8,500
| -71% | -$1.01M |
|
|
109
CALL
Twilio
TWLO
$29B
| $393K | 0.06% |
+4,000
| New | +$409K |
|
|
QTNT
110
DELISTED
Quotient Limited Ordinary Shares
QTNT
| $380K | 0.06% |
1,000
-250
| -20% | -$82.9K |
|
111
AstraZeneca
AZN
$266B
| $374K | 0.06% |
+3,750
| New | +$353K |
|
|
SPLK
112
DELISTED
Splunk Inc
SPLK
| $374K | 0.06% |
+2,500
| New | +$328K |
|
|
BPMC
113
DELISTED
Blueprint Medicines
BPMC
| $360K | 0.06% |
+4,500
| New | +$337K |
|
114
Sony
SONY
$134B
| $340K | 0.05% |
25,000
-5,000
| -17% | -$62.3K |
|
115
Centene
CNC
$30.1B
| $314K | 0.05% |
5,000
-65,000
| -93% | -$3.53M |
|
|
BLUE
116
DELISTED
bluebird bio
BLUE
| $307K | 0.05% |
+270
| New | +$293K |
|
117
Mueller Water Products
MWA
$3.9B
| $300K | 0.05% |
+25,000
| New | +$286K |
|
118
ADMA Biologics
ADMA
$2.01B
| $298K | 0.05% |
74,600
-31,900
| -30% | -$139K |
|
119
Cerus
CERS
$579M
| $295K | 0.05% |
70,000
-10,000
| -13% | -$43.1K |
|
|
VIA
120
DELISTED
Via Renewables, Inc. Class A Common Stock
VIA
| $277K | 0.04% |
6,000
+4,000
| +200% | +$200K |
|
|
SIEN
121
DELISTED
Sientra, Inc.
SIEN
| $268K | 0.04% |
3,000
| – | – |
|
|
MRTX
122
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $258K | 0.04% |
+2,000
| New | +$193K |
|
|
AZRE
123
DELISTED
Azure Power Global Limited
AZRE
| $252K | 0.04% |
20,000
-24,802
| -55% | -$314K |
|
124
Tesla
TSLA
$1.22T
| $251K | 0.04% |
+9,000
| New | +$195K |
|
125
Harrow
HROW
$1.45B
| $233K | 0.04% |
30,000
+5,000
| +20% | +$29K |
|
Similar funds
NA
MK
QIM
JVBC
TFP
UWPG
LOAMU
FWM
Ardsley Advisory Partners's Q4 2019 Portfolio in Review
As of Q4 2019, Ardsley Advisory Partners held 210 positions worth $627M, up 41% from $446M the previous quarter. Its ten largest holdings account for 47% of the portfolio.
Ardsley Advisory Partners deployed $130M of net new capital in Q4 2019, opening 76 new positions and adding to 33 existing holdings. Its largest new stake was State Street SPDR S&P Biotech ETF: 110,000 shares worth $10.5M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 29% a quarter earlier, followed by Healthcare and Industrials.
On the sell side, the largest reduction was Walt Disney, an estimated $10.6M trimmed.
- Ardsley Advisory Partners's largest Q4 2019 buy was State Street SPDR S&P Biotech ETF: 110,000 shares worth $10.5M.
- Ardsley Advisory Partners added most to Guardant Health in Q4 2019, an estimated $17.7M increase.
- Ardsley Advisory Partners's biggest Q4 2019 reduction was Walt Disney, cutting an estimated $10.6M.
- Ardsley Advisory Partners fully exited Medifast in Q4 2019, selling an estimated $9.84M.
- Ardsley Advisory Partners's ten largest holdings make up 47% of its $627M portfolio in Q4 2019.
- Ardsley Advisory Partners opened 76 new positions and closed 60 in Q4 2019.
- Ardsley Advisory Partners's portfolio value rose 41% quarter-over-quarter to $627M.
Based on Ardsley Advisory Partners's 13F filing for Q4 2019, filed 14 Feb 2020.